Withdrawal of dopamine agonist therapy in prolactinomas: In which patients and when? [electronic resource]
Producer: 20170322Description: 303-10 p. digitalISSN:- 1573-7403
- Adolescent
- Adult
- Aged
- Bromocriptine -- administration & dosage
- Cabergoline
- Deprescriptions
- Dopamine Agonists -- administration & dosage
- Ergolines -- administration & dosage
- Female
- Humans
- Hyperprolactinemia -- blood
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- blood
- Patient Selection
- Pituitary Neoplasms -- blood
- Prolactin -- blood
- Prolactinoma -- blood
- Retrospective Studies
- Time Factors
- Tumor Burden
- Young Adult
No physical items for this record
Publication Type: Journal Article; Observational Study
There are no comments on this title.
Log in to your account to post a comment.